Imatinib, sold under the brand names Gleevec among others, is a chemotherapy
medication used to treat cancer. Specifically it is used for chronic myelogenous ...
Dec 15, 2016 ... Imatinib is used to treat certain types of leukemia (cancer that begins in the white
blood cells) and other cancers and disorders of the blood cells ...
Jan 6, 2017 ... Easy to read patient leaflet for imatinib. Includes indications, proper use, special
instructions, precautions, and possible side effects.
Find patient medical information for imatinib oral on WebMD including its uses,
side effects and safety, interactions, pictures, warnings and user ratings.
Feb 11, 2015 ... Read about the cancer treatment drug imatinib, otherwise known as Glivec,
including what it is, how it works and possible side effects.
Oct 5, 2006 ... This page contains brief information about imatinib mesylate and a collection of
links to more information about the use of this drug, research ...
(eye-MAT-eh-nib mez-i-late). Trade name: Gleevec<sup>TM</sup> Other names: STI-571.
Gleevec is the trade name for the generic drug name Imatinib Mesylate. STI-571
Medscape - Leukemia dosing for Gleevec (imatinib), frequency-based adverse
effects, comprehensive interactions, contraindications, pregnancy & lactation ...
Learn about GLEEVEC® (imatinib mesylate), approved for the treatment of KIT+
GIST and Ph+ CML. See full Safety and Prescribing Information.
Oct 24, 2016 ... Imatinib is a small molecule kinase inhibitor. Gleevec film-coated tablets contain
imatinib mesylate equivalent to 100 mg or 400 mg of imatinib ...